Amyloidopathy is a major hallmark of AD and consists in the abnormal accumulation in the brain parenchyma of the amyloid-β peptide (Aβ), an aggregation-prone protein fragment of 40–42 amino acids produced by the cleavage of amyloid precursor protein (APP). Here, APP is linked to Alzheimer disease.